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Abstract. The aims of this study are to investigate antimicrobial and antibiofilm activities of Ficus 
deltoidea (F. deltoidea) leaves extract against Candida albicans (C. albicans). Methods: The antifungal 
activity was evaluated using minimum inhibitory concentration (MIC) and minimum fungicidal 
concentration (MFC). The potential of F. deltoidea leaves extract as antibiofilm agent was evaluated using 
biofilm inhibition assay and biofilm eradication assay. Chlorhexidine 0.12% (CHX) was used as a positive 
control. Each experiment was performed in triplicate and repeated four times independently. All the data 
obtained were analysed using SPSS version 23. Statistical significance measured using Kruskal Wallis test 
and post-hoc Mann Whitney test which presented as means ±SD with P value <0.001. Results: F. deltoidea 
extract showed antifungal activity against C. albicans with MIC and MFC, 50mg/ml and 100mg/ml 
respectively.  The extract exhibited inhibitory effect on candida biofilm formation (69.5%). The preformed 
biofilm was significantly dispersed by extract upon 5 minutes treatment with eradication percentages 
66.63%. The biofilm inhibition and biofilm eradication percentages for positive control CHX 0.12% were 
43.0% and 58.97% respectively.  Conclusion: Results of this study suggest the potential of F. deltoidea 
leaves extract as preventative and therapeutic agents against candida biofilm-related infections such as oral 
candidiasis and denture stomatitis. 
1. Introduction 
Candida albicans (C. albicans) is a polymorphic 
opportunistic fungus that has the potential to cause life-
threatening systemic infections. 75% of the population of 
Candida species including C. albicans are found present 
in the oral cavity of a healthy individual and generally 
remains latent [1]. However, this species has the ability 
to disseminate to non-commensal niches, resulting in 
hazardous colonization and invasive disease in an 
immunocompromised patient with the support of wide 
range of their virulence factors which includes 
recognition biomolecules (adhesins), morphogenesis (the 
reversible transition between unicellular yeast cells and 
filamentous, growth forms), secreted aspartyl proteases 
and phospholipases [2,3]. In an immunosuppressed 
individual, C. albicans can cause oral infections such as 
oral candidiasis and denture stomatitis. 
Oral candidiasis is a common oral opportunistic 
infection caused by overgrowth of Candida species 
especially C. albicans [4]. The incidence of C. albicans 
isolated from the oral cavity has been reported to be 
50%–65% of people who wear removable dentures [4]. 
Denture is one of the predisposing factors that may lead 
to transition of commensal to pathogenic Candida [5]. 
Globally, denture stomatitis is nominated as the top 
problem that arises for denture wearers. Candida-
associated denture stomatitis is known to be one out of 
seven of the most common fungal infections caused by C. 
albicans involving oral mucosa [6]. Several studies have 
shown that 70% of individuals who wear removable 
complete dentures experience denture stomatitis [7]. 
This infection usually happens in elderly denture 
wearing population [7] and more frequently occur in 
women than men [8]. However, there is no 
discrimination based on racial predilection yet to be 
identified [9].   
Various treatments have been suggested for relieving 
denture stomatitis and oral candidiasis. Basically, the 
treatment of denture stomatitis is done through denture 
cleaning procedures, discontinuation of nocturnal 
denture wearing, denture replacement or realignment, 
topical or systemic antifungal agents, microwave 
irradiation, disinfect solution such as   chlorohexidine 
(CHX) and sodium hypochlorite in which patient needs 
to immerse the denture into the solution for overnight for 
optimal effect [10]. However, disinfection technique has 
minor side effects such as staining of the prosthesis and 
can cause reduce in appetite. Nowadays, the most 
common of antifungal agents have been suggested for 
relieving and treating denture stomatitis are nystatin, 
amphotericin B, miconazole, ketoconazole and 
fluconazole [11]. However, few issues in relation with 
the use of antifungal agents have been arisen due to 
fungal resistance and drug toxicity. The undesirable 
effects from the drugs that might happened are nausea, 
vomiting, hepatotoxic and nephrotoxic effects [12]. 
Miconazole gel associated with warfarin coagulation. 
There are also high recurrence rates of denture stomatitis 
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and recolonization with candida when stopping the 
antifungal treatments [12].  
Nowadays, herbal medicine has gain popularity and it is 
considered as a therapeutic agent [13]. Ficus deltoidea 
(F. deltoidea) is considered one of the herbal plants that 
is widely used, especially by the Malay population. It is 
a green shrub that falls under Moraceae family and 
usually known as mas cotek [13]. Traditionally, the fruits 
are chewed to relieve toothache [13].  Until now, many 
scientific researches on this plant has been conducted 
which it possesses variety of pharmacological activities. 
These include anti-inflammatory activity [14]; anti-
nociceptive activity [15]; anti-diabetic activity and anti-
oxidant activity [16]. Meanwhile, there is a study 
conducted reveals that F. deltoidea effectively 
accelerates oral ulcer healing process and significantly 
found no toxic effect [13]. In spite of these evidences, 
the effect of F. deltoidea on antifungal activity has lack 
scientifically documented. Thus, the aims of this study 
are to investigate antimicrobial and antibiofilm activities 
of F. deltoidea leaves extract against C. albicans. 
2. Material and Methods 
2.1 Preparation of the extract 
F. deltoidea leaves extract was prepared following the 
methodology proposed by Sánchez et al. 2010 [17], with 
minor modifications.  
2.2 Determination of minimum inhibitory 
concentration (MIC) and minimum fungicidal 
concentration (MFC)  
The MIC analysis was performed in BHI broth (BHIB) 
via broth micro-dilution techniques according to Clinical 
and Laboratory Standards Institute [18].  
 
2.3 Determination of biofilm inhibition - 
inhibition of initial candida cell attachment. 
illustrations  
The plant extract at subMIC concentrations were 
evaluated for their inhibition potential against cell 
attachments (antiadhesion test) according to method 
described by Bazargani et al., 2016 [19]. The percentage 
of biofilm formation inhibition was calculated using the 
following formula: 
Biofilm 
inhibition %=  
OD negative control-OD test/ OD 
negative control 
X 100 
2.4 Eradication of biofilm  
The eradication of biofilm formation of the extract was 
performed according to methods described by Bazargani 
et al., 2016 [19]. Percentage eradication was calculated 
by using the following equation: 
Biofilm 
eradication %=  
1- OD negative control-OD test/ 
OD negative control 
X 100 
3. Results 
3.1 Minimum inhibitory and minimum 
fungicidal concentration (MFC) 
Minimum Inhibition Concentration (MIC) and Minimum 
Fungicidal Concentration (MFC) of F. deltoidea leaves 
extract on C. albicans determined using the broth 
microdilution method outlined by the Clinical and 
Laboratory Standard Institute (CLSI) with minor 
modifications (CLSI, 2009). From the result, F. 
deltoidea leaves extract showed antifungal activity 
against C. albicans with MIC and MFC, 50mg/ml and 
100mg/ml respectively. 
3.2 Biofilm eradication assay 
Based on the biofilm eradication result as shown in 
Figure 3, the effect of F. deltoidea leaves extract had 
significantly (p<0.001) increasing the percentage of 
biofilm eradication, as compared to CHX 0.12%. 
Percentage of biofilm eradication by F. deltoidea leaves 
extract with concentration of 50mg/ml was 66.63 ± 
0.32%, 25 mg/ml was 21.13 ± 0.84%, 12.5mg/ml ± 
0.62% whereas for biofilm treated with CHX 0.12% was 
58.97 ± 0.53%. 
Fig. 1. The effect of C. albicans eradication after treated with F. 
deltoidea and CHX 0.12%. The overall percentage of biofilm 
eradication obtained from 4 sets of experiments in triplicates 
(n=12) is presented in a bar graph. (*) indicates significant 
differences in mean percentages were compared to the 
untreated control (p < 0.001) according to the non-parametric 
Kruskal Wallis test with Mann Whitney. Different letters 
indicate statistically significant differences between groups.  
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3.3 Biofilm inhibition assay 
Based on the biofilm inhibition result as shown in Figure 
4, the effect of F. deltoidea leaves extract had 
significantly (p<0.001) increasing the percentage of 
biofilm inhibition, as compared to Chlorhexidine 0.12%. 
Percentage of biofilm inhibition by F. deltoidea leaves 
extract with concentration of 50mg/ml was 69.5 ± 0.93%, 
25 mg/ml was 51.52 ± 1.11%, 12.5mg/ml 1.39 ± 0.82% 
whereas for biofilm treated with CHX 0.12% was 43 ± 
0.71%. 
 
Fig. 2. Figure shows the effect of C. albicans inhibition after 
treated with F. deltoidea and CHX 0.12%. The overall 
percentage of biofilm eradication obtained from 4 sets of 
experiments in triplicates (n=12) is presented in a bar graph. 
(*) indicates significant differences in mean percentages were 
compared to the untreated control (p < 0.001) according to the 
non-parametric Kruskal Wallis test with Mann Whitney. 
Different letters indicate statistically significant differences 
between groups. 
4. Discussion 
In this study, the antifungal activity (MIC and MFC) of 
methanolic leaves extract of F. deltoidea was tested 
against C.albicans. The antibiofilm activity of 
F.deltoidea leaves extract was dose- dependent. The 
leaves extract was found to exhibit antifungal activity 
against C. albicans with a concentration of 50mg/mL for 
MIC and 100 mg/ml for MFC. The biofilm inhibition 
assay shows that 69.5% of C. albicans biofilm is 
dispersed by the extract at the concentration of 50mg/ml 
verifying a significantly higher as compared to control, 
CHX 0.12% with 43% of inhibition activity. Meanwhile 
for the eradication activity at the concentration of 
50mg/ml, the C. albicans biofilm is disrupt by the F. 
deltoidea leaves extract with percentage of 66.63% and 
for the positive control, CHX 0.12% showing only 
58.97%. Our study result is in agreement with 
AbdSamah et al.2012 [20]. The results obtained prove 
that F. deltoidea has an antibiofilm activity against C. 
albicans biofilm and has potential to be used in 
managing denture stomatitis and oral candidiasis.  
 
F. deltoidea usage in traditional treatment can be 
clarified scientifically by studying the presence of its 
phytochemical constituents. A number of previous 
studies reported that inhibition of biofilm formation 
could be explained by the presence of tannins, 
phlobatannins, saponins, flavonoids, steroids, terpenoids, 
cardiac glycosides, alkaloids, anthraquinones and 
polyphenols [21]. Thus, further is required to identify the 
specific phytocompounds that exhibit the antifungal 
properties F. deltoidea leaves extract has a significant 
effect towards C. albicans activity in which it has greater 
anti-fungal activity compared to CHX 0.12%. This 
preliminary study provides a basis or platform for further 
research regarding the therapeutic effect of F. deltoidea 
as an anti-fungal agent. 
5. Conclusion 
Our preliminary study has successfully identified the 
antifungal activity of F. deltoidea leaves extract against 
C. albicans. It’s shows that the methanolic leaves extract 
has the potential as an antifungal agent. These findings 
may help us to do further research on investigating the 
mechanism of action of F. deltoidea on biofilm of 
Candida via acrylic resin and also studying on the 
underlying inhibition mechanism at the molecular level. 
It is believed that F. deltoidea has a great potential as an 
alternative treatment of C. albicans infection in the oral 
cavity.  
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